Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Federica, Borghi"'
Autor:
Michael Tapera, Federica Borghi, Jan Lukas Mayer-Figge, Fabia Mittendorf, Ibrahim-Ethem Celik, Adrián Gómez-Suárez, Stefan F. Kirsch
Publikováno v:
Molecules, Vol 29, Iss 15, p 3710 (2024)
Herein, we report a concise and efficient formal synthesis of (+)-hannokinol. Key to this new strategy is the use of a chiral Horner–Wittig reagent, readily available from 2-deoxy-D-ribose, to introduce the chiral 1,3-diol motif.
Externí odkaz:
https://doaj.org/article/bb1dccd0ed3240f6aef22f9723bc06af
Autor:
Simone Vasilij Benatti, Serena Venturelli, Natalia Comi, Federica Borghi, Stefania Paolucci, Fausto Baldanti
Publikováno v:
The Lancet. Infectious diseases. 22(9)
Publikováno v:
European Journal of Organic Chemistry. 2020:4389-4398
Autor:
Stefano, Zoroddu, Paola, Corona, Luca, Sanna, Federica, Borghi, Valentina, Bordoni, Battistina, Asproni, Gerard A, Pinna, Luigi, Bagella, Gabriele, Murineddu
Publikováno v:
European Journal of Medicinal Chemistry. 238:114440
A small library of novel 1,3,4-oxadiazole bioisosteres was synthesized and their cytotoxic activity evaluated in vitro. Five of the new derivatives (3, 6, 11, 14 and 15) showed high potency against different human cancer cell lines, with 14 being the
Autor:
Eugenia Di Meco, Giuliano Rizzardini, Francesca Bai, Antonio Cascio, Anna Maria Cattelan, Federica Tordato, Evelyn Van Hauwermeiren, Massimo Puoti, Chiara Aldieri, Maria Cristina Moioli, Francesco Castelli, Giulia Marchetti, Guglielmo Migliorino, Paola Morelli, Barbara Menzaghi, Federica Borghi, Marco Rizzi, Antonella d'Arminio Monforte, Annalisa Saracino, Francesca Raumer
Objectives: We evaluated the efficacy and safety of dalbavancin in ABSSSI and ‘other sites’ infections’ (OTA). Methods: Observational study involving 11 Italian hospitals including patients that received ≥1 dose of dalbavancin in 2016–2019.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7c0eed3b60f2fdf1c777adb28a556e
http://hdl.handle.net/10447/510206
http://hdl.handle.net/10447/510206
Autor:
Giulia Marchetti, Paola Nasta, Francesca Bai, Francesca Gatti, Giusi Maria Bellistrì, Camilla Tincati, Federica Borghi, Giampiero Carosi, Massimo Puoti, Antonella d'Arminio Monforte
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e32028 (2012)
Microbial translocation (MT) through the gut accounts for immune activation and CD4+ loss in HIV and may influence HCV disease progression in HIV/HCV co-infection. We asked whether increased MT and immune activation may hamper anti-HCV response in HI
Externí odkaz:
https://doaj.org/article/15e2808bbe0647a88d7e0d9856f692ce
Autor:
Federica Borghi, Federica Ottoni
Publikováno v:
Procedia Engineering. 161:1662-1668
Historic rural settlements are essential evidences of the Italian cultural heritage because they hand precious architectural, historical and environmental values. Despite its importance, this heritage is rarely protected by specific laws and a great
Autor:
Giampiero Carosi, Francesca Gatti, Giuliana Cologni, A. Matti, Antonella Ricci, Viviana Bergamaschi, Paola Nasta, Massimo Puoti, Federica Borghi
OBJECTIVES To investigate the association between insulin resistance and rapid virologic response. DESIGN All consecutive HIV/hepatitis C virus coinfected patients who started peg-interferon alpha-2a (180 microg/week) and ribavirin 1000-1200 mg/day w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61801b6898ee75a11feaec2e619af6b
http://hdl.handle.net/11379/21362
http://hdl.handle.net/11379/21362
Autor:
Giusi M. Bellistrì, Giulia Marchetti, Giampiero Carosi, Francesca Bai, Camilla Tincati, Paola Nasta, Massimo Puoti, Federica Borghi, Antonella d'Arminio Monforte, Francesca Gatti
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 2, p e32028 (2012)
PLoS ONE, Vol 7, Iss 2, p e32028 (2012)
Objectives Microbial translocation (MT) through the gut accounts for immune activation and CD4+ loss in HIV and may influence HCV disease progression in HIV/HCV co-infection. We asked whether increased MT and immune activation may hamper anti-HCV res